Pembrolizumab Versus Methotrexate, Docetaxel, or Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (Keynote-040) : Subgroup Analysis by Pattern of Disease Recurrence

AuthID
 P-00Z-C2R
16
Author(s)
Harrington, KJ
·
Soulières, D
·
Licitra, L
·
Ahn, MJ
·
Soria, A
·
Machiels, JP
·
Mach, N
·
Mehra, R
·
Burtness, B
·
Swaby, RF
·
Lin, J
·
Ge, J
·
Lerman, N
·
Le Tourneau, C
Tipo de Documento
Article
Year published
2023
Publicado
in ORAL ONCOLOGY, ISSN: 1368-8375
Volume: 147
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 37925894
SCOPUS: 2-s2.0-85175709609
Wos: WOS:001108199800001
Source Identifiers
ISSN: 1368-8375
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text
Full Text @ sfx.b-on.pt

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service